Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury
Clinical trial NCT04096950 · COMPLETED
Trial details
- NCT number
- NCT04096950
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-19
- Primary completion
- 2021-01-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.